Christopher & Dana Reeve Foundation’s Post

Wondering about #LynchSyndrome and how LS CancerDiag steps in? Check out this video ⬇️

Sheree Palmer’s life took an unexpected turn in 2008 when she suffered a spinal embolism. As a result, Sheree sustained a spinal cord injury and became a paraplegic, forever changing her life. Today, Sheree is sharing her story and experience of being part of 💥Project Spark and our eWALK* neurostimulation trial. Prior to going on the trial, Sheree was completely unable to walk, but fast forward 12 weeks and she had progressed so much. ✨ To learn more about Sheree's story visit: https://lnkd.in/gZu6nj4A *Important information: eWALK is a rigorous double blinded sham controlled clinical trial. Every volunteer receives 12 weeks of intensive exercise therapy. However, volunteers and scientists do not know whether a volunteer is receiving real or sham stimulation. This information will be available when eWALK results are finalised, which is anticipated to be in the first half of 2025. #ProjectSparkAppeal #SpinalCordInjury #fundraisingforacure #Neurostimulation

Join us for Challenge 79 this September! The idea is simple: do anything you like, in any way you want, with anyone you choose—all centred around the number 79. Go solo, team up with friends, get your workplace or school involved, or make it a family challenge. The possibilities are endless! Duchenne muscular dystrophy is a life-altering diagnosis with limited treatment options and no cure. Children, young people, and their families need support throughout their entire journey—more funding for treatments, a more inclusive society, and care for the whole family as they navigate this challenging condition. They need hope for a brighter future. With your help, we can be there every step of the way for families who rely on us. Together, we can change their future. What can YOU do? https://lnkd.in/ebAPMTvU

💡 Interesting #lupus #SLE clinical trial design hopefully will help learn how to improve future studies. https://lnkd.in/dkdmqUkQ 👉 It identified groups of patients with similar genetic expression patterns (assessed by RNA), showing that particular endotypes responded well to the studied biologic. 🔥 I also was fascinated by the study design. They treated all patients with 2 doses of 60 mg methylprednisolone (weeks 0 and 2), withdrew immunosuppressants at time 0, and then tested with placebo vs the study drug. 🧪 The primary endpoint was the time it took to flare. 💊 This is an exciting way to get around the background noise of other immunosuppressants that plague other clinical trials. I don't know if this will be the wave of the future, but it makes theoretical sense that this may be an excellent way to conduct a lupus trial. 🙏 I look forward to continued improvements in SLE studies and, hopefully, in the future, base them upon patients with particular immunologic pathway abnormalities (endotypes) rather than on a heterogeneous group of patients where many of them have little likelihood of responding to the study drug (based upon its mechanism of action). I am optimistic. Medspoke Oklahoma Medical Research Foundation Joan Merrill Joel Guthridge, Ph.D. Joshua June Fotios Koumpouras Anca Askanase Arezou KhosroshahiSaira Sheikh Mark Matijevic Sujata Arora Xiaodong Wang Minggeng Gao Stephen Wax Judith A. James MD, PhD Debra Jeske Zack, MD, PhD

Love this. It’s a great example of the theory-application gap. What’s the point of learning stuff that has no practical application. It just takes up headspace ! When deciding what training to do, ask ‘ how will this benefit my client?’ Find out more in my newsletter’The Super Coaches are Coming’ #therapeuticcoaching #coachtraining #mastercoach #thesupercoachesarecoming

Learn Krebs Cycle ➡️ Forget Krebs Cycle

Treating pleural effusion? Good news! Now the millions of individuals diagnosed with pleural effusion each year have the option to use Renova in their thoracentesis procedure. Learn more about RenovaRP Centesis here: https://lnkd.in/g6ZG6MCi #ForDignityForLife #pleuraleffusion #thoracentesis #Laborie

Breakthrough spinal patch uses natural body motion to repair herniated discs https://flip.it/6MmOji

On March 31st, for World Theranostics Day, we celebrate how Theranostics is connecting healthcare. Theranostics isn't just about treating diseases; it's about treating individuals. By combining diagnostic and therapeutic tools, it enables personalized medicine, and helps improve accuracy and increase efficiency.. Our commitment to innovation extends beyond imaging capabilities. Through initiatives like the Solid Target Platform for our PETtrace cyclotron and the development of StarGuide , innovative digital SPECT/CT powered by CZT, and Omni Legend , digital PET/CT powered by Precision DL software. We’re helping revolutionizing the way clinicians diagnose and treat cancer, improving access to cutting-edge technology and personalized solutions. Let's recognize the impact of #Theranostics on healthcare and commit to advancing precision care for all. https://lnkd.in/ekW9-8TU #GEHealthCare #FutureofHealthcare #WorldTheranosticsDay #PrecisionHealthcare

With Theranostics, physicians specifically target what they see. The goal is to target the tumor selectively and spare the normal organs. For that, they need post treatment SPECT/CT with the highest quality imaging to review. StarGuide our 3D digital SPECT/CT supports nuclear medicine departments around the globe treating Theranostics patients. #worldTheranosticsday